04:57 PM EDT, 09/04/2024 (MT Newswires) -- James Edgemond, CFO and Treasurer, on September 03, 2024, sold 7,785 shares in United Therapeutics ( UTHR ) for $2,821,050. Following the Form 4 filing with the SEC, Edgemond has control over a total of 3,162 shares of the company, with 3,162 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1082554/000141588924022784/xslF345X05/form4-09042024_040904.xml